On treatment HDL-C levels and risk of major cardiovascular events in the IDEAL trial

被引:0
|
作者
Holme, I.
Gaffney, M.
Cater, N. B.
Kastelein, J. J. P.
Olsson, A. G.
Tikkanen, M. J.
Lindahl, C.
Pedersen, T. R.
机构
[1] Ullevaal Univ Hosp, Oslo, Norway
[2] Pfizer Inc, New York, NY USA
[3] Acad Hosp, Amsterdam, Netherlands
[4] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[5] Helsinki Univ Hosp, Helsinki, Finland
[6] Pfizer Sweden, Taby, Sweden
关键词
D O I
10.1016/S1567-5688(07)71751-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:197 / 197
页数:1
相关论文
共 50 条
  • [21] Effect of pioglitazone on HDL-C, a cardiovascular risk factor in type 2 diabetes
    Prince, MJ
    Zagar, AJ
    Robertson, KE
    DIABETES, 2001, 50 : A128 - A128
  • [22] Low HDL-C levels may be associated with memory loss and dementia risk
    不详
    FUTURE LIPIDOLOGY, 2008, 3 (04): : 364 - 364
  • [23] High serum levels of HDL-C ameliorate the risk of CHD associated with hyperinsulinemia
    Saku, K
    Zhang, B
    Shirai, K
    Tsuchiya, Y
    CIRCULATION, 1999, 100 (18) : 800 - 801
  • [24] Importance of HDL-c for the Occurrence of Cardiovascular Disease in the Elderly
    de Freitas, Elizabete Viana
    Brandao, Andrea Araujo
    Pozzan, Roberto
    Magalhaes, Maria Eliane
    Fonseca, Flavia
    Pizzi, Oswaldo
    Campana, Erika
    Brandao, Ayrton Pires
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2009, 93 (03) : 231 - 238
  • [25] Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians
    Anup K. Nair
    Paolo Piaggi
    Nellie A. McLean
    Manmeet Kaur
    Sayuko Kobes
    William C. Knowler
    Clifton Bogardus
    Robert L. Hanson
    Leslie J. Baier
    Diabetologia, 2016, 59 : 481 - 491
  • [26] HDL-c is a powerful lipid predictor of cardiovascular diseases
    Bruckert, E.
    Hansel, B.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1905 - 1913
  • [27] HDL-C and triglyceride levels: Relationship to coronary heart disease and treatment with statins
    Gaw, A
    CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (01) : 53 - 62
  • [28] EFFECT OF ENDOTHELIAL LIPASE AND ITS GENE POLYMORPHISM (LIPG 584C/T) ON SERUM HDL-C LEVELS AND CARDIOVASCULAR RISK
    Verma, Rashmi
    Gupta, Santosh Kumar
    Girish, M. P.
    ATHEROSCLEROSIS, 2017, 263 : E194 - E194
  • [29] HDL-C and Triglyceride Levels: Relationship to Coronary Heart Disease and Treatment with Statins
    Allan Gaw
    Cardiovascular Drugs and Therapy, 2003, 17 : 53 - 62
  • [30] Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians
    Nair, Anup K.
    Piaggi, Paolo
    McLean, Nellie A.
    Kaur, Manmeet
    Kobes, Sayuko
    Knowler, William C.
    Bogardus, Clifton
    Hanson, Robert L.
    Baier, Leslie J.
    DIABETOLOGIA, 2016, 59 (03) : 481 - 491